Tea L. Laursen
Randers, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Methanobactin rapidly facilitates biliary copper excretion in a Wilson disease rat model visualised by 64Cu PET/MRI.
Journal: British journal of pharmacology
Published: October 30, 2024
CTX-III in hepatitis C.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 02, 2024
Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease.
Journal: Expert opinion on therapeutic targets
Published: October 07, 2022
Clinical Progression of Metabolic-Associated Fatty Liver Disease Is Rare in a Danish Tertiary Liver Center.
Journal: Journal of clinical medicine
Published: March 01, 2022
The presence of interferon affects the progression of non-alcoholic fatty liver disease.
Journal: Genes and immunity
Published: January 16, 2022
Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases.
Journal: Journal of clinical and translational hepatology
Published: November 12, 2021
Cognitive impairment in stable Wilson disease across phenotype.
Journal: Metabolic brain disease
Published: May 03, 2021
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis.
Journal: Frontiers in medicine
Published: October 09, 2020
Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression.
Journal: Clinical and translational gastroenterology
Published: September 21, 2020
No Effect in Alcoholic Hepatitis of Gut-Selective, Broad-Spectrum Antibiotics on Bacterial Translocation or Hepatic and Systemic Inflammation.
Journal: Clinical and translational gastroenterology
Published: July 09, 2020
Last Updated: 09/26/2026